Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Sclera (Dimethyl fumarate) | Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia. |
||
| Defra (Dimethyl fumarate) | Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia. |
||
| Fingolimod SPC (fingolimod) | Updated recommendations to minimize the risk of drug-induced liver injury (DILI). |
||
| Tecfidera (dimethyl fumarate) | Updated recommendations in the light of cases of progressive multifocal leukoencephalopathy (PML) in the setting of mild lymphopenia |
||
| Gilenya (fingolimod) | Updated recommendations to minimize the risk of drug-induced liver injury (DILI) |
||
| Haldol (Haloperidol) | HALDOL® 5mg/ml (HALOPERIDOL) solution for injection: Incorrect information on route of administration on outer carton |
||
| Esbriet (pirfenidone) | Esbriet (pirfenidone): Important safety update and new recommendations to prevent Drug-Induced Liver Injury (DILI) |
||
| Levon (Levofloxacin Hemihydrate) / Moxiflox (Moxifloxacin) | Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence. |
||
| Tarivid (Ofloxacin) / Tavanic (Levofloxacin) | Systemic and inhaled fluoroquinolones: warning about new risk of heart valve regurgitation/incompetence. |
||
| Revlimid® (Lenalidomide) | Notification of typographical error in the Revlimid® (Lenalidomide) Hard Capsules Patient Information Leaflet (PIL) |
Last update date: 21/04/2024 at 10:00 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.